Ensayos clínicos

Inclusion Criteria:

• Adult patients (18 years or older) who have had a 10-second 12-lead ECG at Mayo Clinic and have a CHA2DS2-VASc ≥ 2 for men or CHA2DS2-VASc ≥3 for women.
• Adult patients who have AI-detected AF and are eligible for anticoagulation will be eligible for the first group of patients.
• Adult patients who do not have AI-detected AF but are similar to the first group in other aspects will be eligible as part of the second group of patients.

Exclusion Criteria:

• Patients with diagnosed atrial fibrillation or atrial flutter, on anticoagulation or have another indication for anticoagulation (e.g., mechanical valve), missing DOB or sex in EHR, history of intracranial bleeding, history of end-stage kidney disease, or have an implantable cardiac monitoring device (pacemaker, debfibrillator, implanted loop recorded).
• Patients who are deemed by research personnel to have limitations that would prevent them from being able to provide informed consent, use the patch, or complete interviews will not be included.